Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alan Bergeron"'
Autor:
Andrew, Box, Laura, Holmes, Monica, DeLay, Dave, Adams, Alan, Bergeron, Karen, Clise-Dwyer, Matt, Cochran, Roxana Del Rio, Guerra, E Michael, Meyer, Kathleen M, Brundage
Publikováno v:
J Biomol Tech
Cells isolated using electrostatic cell sorters are subsequently evaluated in a variety of in vitro and in vivo applications. Thus, manipulations to the cells during the pre- and post-sort processing as well as when the cells are being analyzed by an
Autor:
William F. C. Rigby, Benjamin M. Terry, Brian L. Henry, Xiao Wei Wang, Moe Zan, Jane E. Collins, Daniel Bloch, B. JoNell Hamilton, Alan Bergeron, Andrew J. Mouland
Publikováno v:
Journal of Biological Chemistry. 283:25606-25616
We report a role for CA repeats in the 3′-untranslated region (3′-UTR) in regulating CD154 expression. Human CD154 is encoded by an unstable mRNA; this instability is conferred in cis by a portion of its 3′-UTR that includes a polypyrimidine-ri
Autor:
B JoNell, Hamilton, Xiao-Wei, Wang, Jane, Collins, Donald, Bloch, Alan, Bergeron, Brian, Henry, Benjamin M, Terry, Moe, Zan, Andrew J, Mouland, William F C, Rigby
Publikováno v:
The Journal of biological chemistry. 283(37)
We report a role for CA repeats in the 3′-untranslated region (3′-UTR) in regulating CD154 expression. Human CD154 is encoded by an unstable mRNA; this instability is conferred in cis by a portion of its 3′-UTR that includes a polypyrimidine-ri
Autor:
Daniel Mielcarz, Alan Bergeron, John DeLong, Kathleen Smith, Alexandra Heyn, Karen Mack, Mary Ann Conrad, Brant Oliver, Lloyd Kasper, Jacqueline Channon
Publikováno v:
The Journal of Immunology. 188:116.9-116.9
Recent studies provide strong evidence for a role for B cells in the pathology of RRMS. In order to explore the effect of IFNbeta-1b treatment on B cell phenotype and function in RRMS patients, blood was drawn from 10 RRMS patients before treatment a
Autor:
Brant J Oliver, Kathleen Smith, John DeLong, Daniel Mielcarz, Alan Bergeron, Karen Mack, Lloyd H. Kasper, Alexandra Heyn, Jacqueline Y. Channon
Publikováno v:
Neurology. 78:P02.086-P02.086
Objective: The hypothesis tested is that B cell subsets in RRMS patients differ from healthy controls and that treatment with IFN-1b alters these subsets. Background Therapy directed at the depletion of CD20+ B cells has been shown in Phase II clinic